GlassScriptPhysician profile
Kari Hess Bailey
NPI 1831484476
$6,685.56
in general payments reported to CMS, 2019-2025
37 companies · $894 in 2025
The $894 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $547 · 2020: $82.61 · 2021: $1,453 · 2022: $758 · 2023: $1,989 · 2024: $962 · 2025: $894.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,920 · Travel and Lodging: $619 · Honoraria: $258 · Education: $48.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,919.61 |
| Travel and Lodging | $619.36 |
| Honoraria | $257.63 |
| Education | $48.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $2,570.64 | 2021-2024 | Axonics, Bulkamid |
| Valencia Technologies Corporation | $649.40 | 2023 | Ecoin Device Kit |
| Abbvie INC. | $405.15 | 2019-2025 | Botox |
| Sumitomo Pharma America, INC. | $389.51 | 2023-2025 | Gemtesa |
| Boston Scientific Corporation | $372.60 | 2019-2025 | Axonics, Ams 700, Ams 800 Artificial Urinary Sphincter |
| Astellas Pharma US INC | $323.10 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Dendreon Pharmaceuticals LLC | $251.05 | 2024-2025 | Provenge |
| Myriad Genetic Laboratories, INC. | $144.64 | 2023 | Prolaris |
| Renovia INC | $144.13 | 2019-2020 | |
| Baxter Healthcare | $122.94 | 2024 | Tisseel, Preveleak |
| Bayer Healthcare Pharmaceuticals INC. | $107.00 | 2019-2025 | |
| Pfizer INC. | $104.01 | 2019-2020 | |
| Urogen Pharma, INC. | $97.26 | 2023 | Jelmyto |
| Immunitybio, INC. | $90.75 | 2025 | |
| Ferring Pharmaceuticals INC. | $89.98 | 2025 | Adstiladrin |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tempus Ai, INC | $88.31 | 2024 | Xt Cdx |
| Urovant Sciences INC | $87.24 | 2021-2022 | |
| Coloplast Corp | $87.01 | 2019-2023 | Titan |
| Allergan, INC. | $62.28 | 2019-2022 | |
| Myovant Sciences INC. | $60.81 | 2021-2022 | |
| Olympus America INC. | $52.65 | 2023-2025 | Itind System, Tecoflex |
| Endo Pharmaceuticals INC. | $51.74 | 2019-2023 | Xiaflex, Aveed |
| Antares Pharma, INC. | $44.17 | 2019-2025 | Xyosted |
| Janssen Biotech, INC. | $39.48 | 2022-2024 | Akeega, Erleada |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Millicent US INC | $32.48 | 2023-2024 | Intrarosa, Femring |
| Bioprotect Medical, INC. | $21.93 | 2025 | Bioprotect Balloon Implant System |
| Merck Sharp & Dohme LLC | $20.53 | 2025 | Keytruda |
| Telix Pharmaceuticals | $19.36 | 2023 | Illuccix |
| Verity Pharmaceuticals INC. | $16.87 | 2025 | Trelstar |
| Endo USA, INC. | $16.36 | 2024 | Xiaflex, Aveed |
| 180 Medical, INC. | $16.35 | 2023 | Gentlecath |
| Medtronic, INC. | $15.80 | 2024 | Interstim |
| Sagent Pharmaceuticals | $15.37 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $13.51 | 2024 | |
| Laborie Medical Technologies Corp. | $13.27 | 2022 | |
| Therapeuticsmd, INC. | $12.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kari Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.